Back to search

University of Washington

Investigating Discrepancies in School-Based Deworming Coverage Estimates from the DeWorm3 Trial

Abstract

dc:description.abstract

Abstract Background: Soil Transmitted Helminths (STH) infect over 1.5 billion people globally, causing anemia and growth stunting that result in an annual toll of 1.9 million Disability-Adjusted Life Years. School-based deworming (SBD) via Mass Drug Administration (MDA) campaigns with albendazole or mebendazole has been recommended by the World Health Organization to reduce the prevalence of STH in endemic areas. The DeWorm3 Trial is a cluster randomized trial investigating the feasibility of interrupting the transmission of STH with community-wide MDA for three study sites in Benin, India, and Malawi. Methodology/Principal Findings: This analysis examines data from the DeWorm3 Trial to quantify discrepancies between school-level reporting of SBD and gold-standard individual-level survey reporting of SBD available from the DeWorm3 Trial’s intervention arm. Population-weighted averages of school-level SBD were calculated at the cluster level and compared to directly aggregated individual-level estimates of SBD to produce a Mean Squared Error (MSE) estimate for each study site. These MSE values were applied to SBD estimates from the control arm of the DeWorm3 Trial, where only school-level reporting of SBD had been collected, in order to project what coverages would have been for individual-level reporting of SBD. In each site, SBD coverage was reported as being substantially higher in the school-level datasets than in the gold standard individual-level datasets, indicating that school-level SBD reporting may be over-estimating SBD coverage. In Benin, average SBD coverage in the control arm dropped from 89.1% to 70.5% when applying observed MSE to project expected coverages. In India, the expected coverages decreased from 97.7% to 84.5%, and in Malawi, expected coverages decreased from 41.5% to 37.5%. Conclusions/Significance: These estimates indicate that school-level reporting of SBD likely overestimate program reach and effectiveness. These findings suggest that current estimates of coverage derived from school-based program data may substantially overestimate true pediatric deworming coverage.

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Sheahan, William
Advisors dc:contributor.advisor
  • Asbjornsdottir, Kristjana
  • Walson, Judd

Subjects

dc:subject × 7

Rights

dc:rights
Statement dc:rights
  • none
Language dc:language.iso
en_US

Identifiers

dc:identifier.*
Handle dc:identifier.uri
http://hdl.handle.net/1773/47535

Chain of custody

source
Harvested from
University of Washington
Base URL
digital.lib.washington.edu/server/oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Sheahan, William. Investigating Discrepancies in School-Based Deworming Coverage Estimates from the DeWorm3 Trial. 2021. http://hdl.handle.net/1773/47535